Hospitalization costs for radical prostatectomy attributable to robotic surgery

Area of Science:

• Urology
• Health Economics
• Surgical Innovation

Background:

• Health technology advancements contribute to rising healthcare expenditures.
• Accurate cost comparisons between different surgical approaches are crucial for informed decision-making.
• Robot-assisted radical prostatectomy (RARP) and open radical prostatectomy (ORP) are common treatments for prostate cancer.

Purpose of the Study:

• To compare the total hospitalization costs associated with RARP and ORP.
• To analyze the cost-effectiveness of robotic versus open surgery for radical prostatectomy.

Main Methods:

• A population-based cohort study utilized data from the Nationwide Inpatient Sample (NIS) and American Hospital Association (AHA) survey (2006-2008).
• Identified 29,837 patients who underwent radical prostatectomy (RP).
• Used generalized estimating equations to adjust for patient and hospital characteristics, estimating costs for ORP and RARP.

Main Results:

• RARP was performed in 68.5% of patients, while ORP was used in 31.5%.
• RARP patients experienced shorter lengths of stay (1 day vs. 2 days) and fewer postoperative complications (8.2% vs. 11.3%) compared to ORP.
• Median hospitalization costs were higher for RARP ($10,409) than for ORP ($8,862).
• Adjusted analysis confirmed higher total hospitalization costs for RARP ($11,932) versus ORP ($9,390).

Conclusions:

• Despite clinical advantages like reduced complications and shorter hospital stays, RARP is associated with higher total hospitalization costs than ORP.
• The findings highlight a trade-off between clinical outcomes and economic impact in prostatectomy procedures.
• Further research may explore long-term cost-effectiveness and value-based healthcare models for RARP.